Delphinus Medical Technologies

26 articles about Delphinus Medical Technologies

• Delphinus Medical Technologies Appoints Scott A. White as New CEO

  10/3/2023

  Delphinus Medical Technologies today announced the appointment of Scott A. White as the new president and CEO.

• Delphinus Medical Technologies Raises $12 Million as Footprint Continues to Expand

  8/22/2023

  Delphinus Medical Technologies, the pioneers of dense breast medical imaging, announced that it raised $12 million in growth capital from Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies.

• Delphinus Medical Announces Installation of SoftVue Breast Imaging System at UR Medicine

  3/7/2023

  Delphinus Medical Technologies announced today the latest installation of its SoftVue™ 3D Whole Breast Ultrasound Tomography System since FDA approval of its advanced technology for screening women with dense breast tissue.

• Delphinus Medical Technologies to Demonstrate SoftVue™ Whole Breast Ultrasound System at RSNA Annual Meeting

  11/18/2022

  Delphinus Medical Technologies to Demonstrate SoftVue™ Whole Breast Ultrasound System at RSNA Annual Meeting.

• Delphinus Raises $30 Million in Series D Funding to Transform Dense Breast Screening

  9/29/2022

  Delphinus Medical Technologies, Inc. today announced the closing of a $30 million Series D financing.

• Delphinus Receives FDA Approval for its SoftVue 3D Whole Breast Ultrasound Tomography System

  10/12/2021

  Delphinus Medical Technologies, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its SoftVue™ 3D Whole Breast Ultrasound Tomography System (SoftVue™) for use as an adjunct to digital mammography in the screening of asymptomatic women with dense breast tissue.

• Study Finds Potential of Whole Breast Ultrasound Tomography to Improve Breast Cancer Risk Assessment

  3/10/2020

  Researchers Compared Mammography and Whole Breast Ultrasound in Younger Women with Dense Breast Tissue

• Delphinus Medical Technologies Appoints Dr. Rachel Brem to Its Board of Directors

  7/31/2019

  Delphinus Medical Technologies, Inc., the leader in advanced breast ultrasound technology, announced that Rachel Brem, M.D, has joined the company’s board of directors, effective immediately.

• Pharmaceutical Clean Room Qualification Verifies Secure Operation

  7/22/2019

  In the pharmaceutical industry, continuous and secure data acquisition and documentation is crucial for production and storage requirements, and also for research and development.

• Delphinus to Host Dense Breast Subject Experts at RSNA 2017

  11/14/2017

  Delphinus will be gathering subject experts to discuss recent legislation and new technology affecting women with dense breasts during RSNA 2017 in Chicago.

• Delphinus Announces First Patient Enrolled In Clinical Project Comparing Softvue And Mammography In Dense Breast Tissue

  9/6/2017

• Delphinus Appoints Global R&D Leader Bruno Dacquay As New Vice President Of Engineering

  6/13/2017

• Delphinus Eyes Hiring in Relocation of HQ, to Triple Size of Facility

  5/16/2016

• Delphinus Adds Vice President Of Quality, Regulatory Affairs To Team

  12/4/2015

• Delphinus Adds Vice President Of Quality, Regulatory Affairs To Team

  12/1/2015

• Delphinus Scores Over $39 Million in Capital

  9/10/2015

• Heather Rone Joins Delphinus Medical Technologies As Clinical Affairs VP

  1/28/2015

• Delphinus Medical Technologies Awarded 510(k) Clearance For Color Imaging with SoftVue Automated Breast Ultrasound

  12/2/2014

• Shawn O’Brien To Head Finance At Delphinus Medical Technologies

  11/6/2014

• Chris Sanders Added To Delphinus Medical Technologies’ Executive Team As Vice President Of Engineering

  10/14/2014